WHO ICTRP trial
To evaluate the efficacy of Qurse Ziabetes.
CTRI/2021/02/031597 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2021/02/031597 |
|---|---|
| Public title | To evaluate the efficacy of Qurse Ziabetes. |
| Scientific title | An open intervention trial of Qurse Ziabetes ( A formulation of Sabith bin Qurrah) in the secondary prevention of Ziabetes shakri (Diabetes mellitus type-2) |
| Primary sponsor | National Institute of Unani Medicine |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: E119- Type 2 diabetes mellitus without complications |
| Interventions | Intervention1: Qurs Ziabetes: All the dried ingredients are grinded into powdered form and mixed with Luab-e-Asapgoal will be given 7 masha orally Control Intervention1: Not Applicable: Not Applicable |
| Registration date | Feb 26, 2021 |
| Target size | 40 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: